Nuvama Wealth Management Ltd - 543988 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation of ESOP Allotment is attached herewith23-12-2023
Nuvama Wealth Management Ltd - 543988 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation of ESOP Allotment is attached herewithNuvama Wealth Management Ltd - 543988 - Investor Update
Please find attached herewith Investor Update by the Company.Nuvama Wealth Management Ltd - 543988 - Investor Update
Please find attached herewith Investor Update by the Company.Nuvama Wealth Management Ltd - 543988 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith Press Release with respect to Update on SAT Order.Nuvama Wealth Management Ltd - 543988 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation for allotment of ESOP is attached herewith.Nuvama Wealth Management Ltd - 543988 - Disclosure Under Regulation 30 Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Please find attached Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.Nuvama Wealth Management Ltd - 543988 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation for allotment of ESOP is attached herewith.Valuations of midcaps, smallcaps rich, outperformance against largecaps may not continue, says Nuvama
Nuvama underscored that midcaps are also expensive but they should still do relatively better than smallcaps.Citi initiates coverage on Nuvama Wealth with buy', prefers it over 360 One Wealth here's why
Global brokerage house Citi has initiated coverage on AMC Nuvama Wealth Management with a Buy' rating and a target price of 4,110, representing approximately a 27% potential upside. Nuvama's strength lies in its multi-product and open-architecture distribution model in the wealth sector.Rollover Update: Mid- and small-cap indexes shine in November 2023 derivative expiry, says Nuvama
Mid- and small-cap indexes showed remarkable gains in the November 2023 derivative expiry series. The November 2023 derivative expiry series saw a surprising turn of events, with HNIs and retail investors' faith shifting the balance of power in the market's favour, as per brokerage, Nuvama.